Severe congenital heart disease speeds comorbidity onset
In a 35-year study, severe congenital heart disease shifted median comorbidity onset two to three decades earlier than nonsevere disease, doubling cumulative risk by age 40.
Journal of the American Heart Association
Researchers tracked 9,764 individuals with severe congenital heart disease and 127,728 with nonsevere disease in a Quebec cohort over 35 years to map 38 comorbidities. Patients with severe disease developed conditions substantially earlier across life. By age 40, their cumulative probabilities of developing cardiac, vascular, endocrine, metabolic, digestive, infectious, renal, and neurological diseases were at least twofold higher than in nonsevere cases. Most comorbidities had a median onset before age 40 in severe disease, arriving two to three decades earlier than in nonsevere patients, whose peaks occurred between their 60s and 80s. In severe congenital heart disease, disease progression typically began with childhood cardiovascular conditions, shifted to metabolic, hepatic, and renal diseases in early adulthood, and culminated in heart failure and dementia.
Why it matters
The findings show how early-life organ defects can trigger multi-system disease cascades that mirror premature physiological aging. Mapping these trajectories helps aging researchers understand how early cardiovascular damage accelerates secondary organ decline across the lifespan.
Caveats
The investigation was an observational cohort study limited to administrative diagnostic codes within Quebec, which cannot establish direct causality or detect subclinical disease states.
The paper
Changing Comorbidity Clusters in Patients With Congenital Heart Disease Across the Lifespan
Show 8 more authors
Maya D’Angelo, Aihua Liu, Liming Guo, Judith Therrien, Archer Yi Yang, Robyn M Tamblyn, James M. Brophy, Yue Li,Adult Congenital Heart Association
Journal of the American Heart Association · 29 Sep 2026